Publication | Closed Access

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1

Breast OncologyBreast Cancer RiskEndocrine-related CancerHormonal ReceptorGynecologyAcetate-driven IncreaseBreast CancerGrowth FactorsMedicineRadiation OncologyTumor MicroenvironmentCancer ResearchCancer Growth